SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific submits disclosure

04 Jun 2014 Evaluate

Sequent Scientific has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011.

The above information is a part of company’s filings submitted to BSE.

Viyash Scientific Share Price

205.65 -3.40 (-1.63%)
13-Apr-2026 13:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1659.60
Dr. Reddys Lab 1234.45
Cipla 1213.50
Zydus Lifesciences 924.55
Lupin 2323.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×